{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:29:21Z","timestamp":1792787361022,"version":"4.5.0"},"reference-count":101,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001646","name":"Robert-Bosch-Stiftung","doi-asserted-by":"publisher","award":["O3"],"award-info":[{"award-number":["O3"]}],"id":[{"id":"10.13039\/501100001646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The conceptual description of Follicular lymphoma (FL) in the 5th edition of the World Health Organization (WHO) classification of haematolymphoid tumors (WHO-HAEM5) has undergone significant revision. The vast majority of FL (85%) with a follicular growth pattern are composed of centrocytes and centroblasts, harbor the t(14;18)(q32;q21) translocation and are now termed classic FL (cFL). They are set apart from three related subtypes, FL with predominantly follicular growth pattern, FL with unusual cytological features (uFL) and follicular large B-cell lymphoma (FLBCL). In contrast to the revised 4th edition of the WHO classification of haematolymphoid tumors (WHO-HAEM4R), grading of cFL is no longer mandatory. FL with a predominantly diffuse growth pattern had been previously recognized in WHO-HAEM4R. It frequently occurs as a large tumor in the inguinal region and is associated with CD23 expression. An absence of the IGH::BCL2 fusion and frequent STAT6 mutations along with 1p36 deletion or TNFRSF14 mutation is typical. The newly introduced subtype of uFL includes two subsets that significantly diverge from cFL: one with \u201cblastoid\u201d and one with \u201clarge centrocyte\u201d variant cytological features. uFL more frequently displays variant immunophenotypic and genotypic features. FLBCL is largely identical to WHO-HAEM4R FL grade 3B and renaming was done for reasons of consistency throughout the classification. In-situ follicular B-cell neoplasm, pediatric-type FL, duodenal-type FL and primary cutaneous follicle center lymphoma are categorized as discrete entities. In addition, novel findings concerning underlying biological mechanisms in the pathogenesis of early and systemic follicular lymphoma will be presented.<\/jats:p>","DOI":"10.3390\/cancers15030785","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T10:19:28Z","timestamp":1675073968000},"page":"785","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms\u2014Updated Classification and New Biological Data"],"prefix":"10.3390","volume":"15","author":[{"given":"Katrin S.","family":"Kurz","sequence":"first","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, 70376 Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Kalmbach","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, 70376 Stuttgart, Germany"},{"name":"Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of T\u00fcbingen, 70376 Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Pathology, Marienhospital, 70199 Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette M.","family":"Staiger","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, 70376 Stuttgart, Germany"},{"name":"Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of T\u00fcbingen, 70376 Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, 70376 Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Horn","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, 70376 Stuttgart, Germany"},{"name":"Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of T\u00fcbingen, 70376 Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"ref_1","unstructured":"Jaffe, E.S., Harris, N.L., Stein, H., and Vardiman, J.W. (2001). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer Press. [3rd ed.]."},{"key":"ref_2","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W. (2008). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer Press. [4th ed.]."},{"key":"ref_3","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., Arber, D.A., Hasserjian, R.P., and Le Beau, M.M. (2017). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer Press. [Revised 4th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: A report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.annonc.2020.11.008","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dreyling","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41408-020-00340-z","article-title":"Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups","volume":"10","author":"Batlevi","year":"2020","journal-title":"Blood Cancer J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/annonc\/mds429","article-title":"Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): A prospective US patient cohort treated predominantly in community practices","volume":"24","author":"Nooka","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: A retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/S2352-3026(18)30090-5","article-title":"Rituximab and the risk of transformation of follicular lymphoma: A retrospective pooled analysis","volume":"5","author":"Federico","year":"2018","journal-title":"Lancet Haematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.3324\/haematol.2017.175059","article-title":"Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort","volume":"103","author":"Rimsza","year":"2018","journal-title":"Haematologica"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/ajcp\/aqz008","article-title":"Stratification of Follicular Lymphoma: Time for a Paradigm Shift?","volume":"151","author":"Kroft","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1200\/JCO.2017.76.8960","article-title":"Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety","volume":"36","author":"Hiddemann","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJMoa1805104","article-title":"Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma","volume":"379","author":"Morschhauser","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2559.2011.03897.x","article-title":"Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes","volume":"59","author":"Henopp","year":"2011","journal-title":"Histopathology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/his.14617","article-title":"Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: A comprehensive screening study in a Japanese cohort","volume":"80","author":"Oishi","year":"2022","journal-title":"Histopathology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3324\/haematol.2013.085506","article-title":"Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies","volume":"98","author":"Pillai","year":"2013","journal-title":"Haematologica"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: Description and analysis by laser capture microdissection","volume":"99","author":"Cong","year":"2002","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/leu.2009.9","article-title":"In situ localization of follicular lymphoma: Evidence for subclinical systemic disease with detection of an identical BCL-2\/IGH fusion gene in blood and lymph node","volume":"23","author":"Cheung","year":"2009","journal-title":"Leukemia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1172\/JCI72415","article-title":"Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression","volume":"124","author":"Sungalee","year":"2014","journal-title":"J. Clin. Invest."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: Clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","author":"Jegalian","year":"2011","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/leu.2013.307","article-title":"Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma","volume":"28","author":"Schmidt","year":"2014","journal-title":"Leukemia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: A genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.3324\/haematol.2014.115782","article-title":"Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites","volume":"100","author":"Mamessier","year":"2015","journal-title":"Haematologica"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kosmidis, P., Bonzheim, I., Dufke, C., Colak, S., Hentrich, T., Schroeder, C., Bauer, P., Adam, P., and Fend, F. (2017). Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178503"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2018-03-837039","article-title":"CREBBP gene mutations are frequently detected in in situ follicular neoplasia","volume":"132","author":"Schmidt","year":"2018","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1182\/blood-2011-07-368944","article-title":"A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma","volume":"118","author":"Bonzheim","year":"2011","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.3324\/haematol.2020.254854","article-title":"Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype","volume":"106","author":"Vogelsberg","year":"2021","journal-title":"Haematologica"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/path.5861","article-title":"Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma","volume":"256","author":"Dobson","year":"2022","journal-title":"J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V68.4.837.837","article-title":"What should be the morphologic criteria for the subdivision of follicular lymphomas?","volume":"68","author":"Nathwani","year":"1986","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/PAI.0000000000000107","article-title":"Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms","volume":"23","author":"Menter","year":"2015","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/PAS.0000000000001015","article-title":"Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas","volume":"42","author":"Moore","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.humpath.2013.02.004","article-title":"The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-\"negative\" grade 1\/2 follicular lymphomas","volume":"44","author":"Adam","year":"2013","journal-title":"Hum. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2006.10.5833","article-title":"Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: The German Low Grade Lymphoma Study Group","volume":"25","author":"Klapper","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood-2005-12-008755","article-title":"Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma","volume":"108","author":"Chiu","year":"2006","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jncimonographs\/lgn005","article-title":"Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals","volume":"2008","author":"Hirt","year":"2008","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1084\/jem.20061292","article-title":"Follicular lymphoma-like B cells in healthy individuals: A novel intermediate step in early lymphomagenesis","volume":"203","author":"Roulland","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1080\/10428194.2020.1762883","article-title":"Follicular lymphoma genomics","volume":"61","author":"Pickard","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrc.2017.127","article-title":"From genetics to the clinic: A translational perspective on follicular lymphoma","volume":"18","author":"Huet","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Salaverria","year":"2013","journal-title":"Haematologica"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1440-1827.2006.02072.x","article-title":"Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and\/or Bcl6 or p53 expression","volume":"57","author":"Guo","year":"2007","journal-title":"Pathol. Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2141.2003.04086.x","article-title":"Follicular lymphoma lacking the t(14;18)(q32;q21): Identification of two disease subtypes","volume":"120","author":"Horsman","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/leu.2015.330","article-title":"Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus","volume":"30","author":"Leich","year":"2016","journal-title":"Leukemia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","article-title":"Cell of origin of transformed follicular lymphoma","volume":"126","author":"Kridel","year":"2015","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","volume":"114","author":"Leich","year":"2009","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1182\/blood-2011-06-361972","article-title":"MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype","volume":"118","author":"Leich","year":"2011","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/leu.2017.270","article-title":"Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing","volume":"32","author":"Pischimarov","year":"2018","journal-title":"Leukemia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Boss","year":"2015","journal-title":"Nat. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1182\/bloodadvances.2021005081","article-title":"Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage","volume":"5","author":"Leich","year":"2021","journal-title":"Blood Adv."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1097\/HS9.0000000000000767","article-title":"Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas","volume":"6","author":"Horn","year":"2022","journal-title":"Hemasphere"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.2019000560","article-title":"Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles","volume":"135","author":"Staiger","year":"2020","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1182\/bloodadvances.2022008355","article-title":"Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III\/IV","volume":"6","author":"Stevens","year":"2022","journal-title":"Blood Adv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/bjh.17383","article-title":"Pathogenesis of follicular lymphoma: Genetics to the microenvironment to clinical translation","volume":"194","author":"Kumar","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.humpath.2012.03.025","article-title":"The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease","volume":"43","author":"Koch","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1182\/bloodadvances.2020003774","article-title":"Lenalidomide triggers T-cell effector functions in vivo in patients with follicular lymphoma","volume":"5","author":"Rossille","year":"2021","journal-title":"Blood Adv."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1182\/bloodadvances.2020003949","article-title":"A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival","volume":"5","author":"Lamaison","year":"2021","journal-title":"Blood Adv."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.humpath.2017.11.002","article-title":"Follicular large cleaved cell (centrocytic) lymphoma: An unrecognized variant of follicular lymphoma","volume":"72","author":"Laurini","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0000000000001726","article-title":"High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B","volume":"45","author":"Laurent","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjh.15041","article-title":"The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion","volume":"180","author":"Pischimarov","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","article-title":"Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas","volume":"22","author":"Morin","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"27169","DOI":"10.1074\/jbc.M201207200","article-title":"Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL","volume":"277","author":"Wurster","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","article-title":"Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3","volume":"99","author":"Ott","year":"2002","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9440(10)63313-5","article-title":"Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component","volume":"165","author":"Katzenberger","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/annonc\/mdw185","article-title":"Clinical, pathological and genetic features of follicular lymphoma grade 3A: A joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL","volume":"27","author":"Koch","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","article-title":"Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2","volume":"103","author":"Horn","year":"2018","journal-title":"Haematologica"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","article-title":"Pediatric-type nodal follicular lymphoma: An indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement","volume":"120","author":"Louissaint","year":"2012","journal-title":"Blood"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3324\/haematol.2009.013177","article-title":"Pediatric follicular lymphoma\u2014A clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin\u2019s Lymphoma\u2014Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials","volume":"95","author":"Oschlies","year":"2010","journal-title":"Haematologica"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5858\/133.1.142","article-title":"Pediatric follicular lymphoma: A rare clinicopathologic entity","volume":"133","author":"Agrawal","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","article-title":"Novel markers in pediatric-type follicular lymphoma","volume":"475","author":"Agostinelli","year":"2019","journal-title":"Virchows Arch."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2017-03-776278","article-title":"Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation","volume":"130","author":"Schmidt","year":"2017","journal-title":"Blood"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1349-7006.2011.01980.x","article-title":"Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: A multicenter, retrospective analysis in Japan","volume":"102","author":"Takata","year":"2011","journal-title":"Cancer Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","article-title":"Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: A retrospective study of 63 cases","volume":"29","author":"Schmatz","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","article-title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","volume":"132","author":"Hellmuth","year":"2018","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/pin.12740","article-title":"Villous colonization (glove balloon sign): A histopathological diagnostic marker for follicular lymphomas with duodenal involvement including duodenal-type follicular lymphoma","volume":"69","author":"Tsuyama","year":"2019","journal-title":"Pathol. Int."},{"key":"ref_86","first-page":"919","article-title":"Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin\u2019s lymphomas","volume":"150","author":"Drillenburg","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/modpathol.2012.127","article-title":"Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics","volume":"26","author":"Takata","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/cas.12392","article-title":"Duodenal follicular lymphoma: Comprehensive gene expression analysis with insights into pathogenesis","volume":"105","author":"Takata","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jcp.2007.049825","article-title":"Duodenal follicular lymphomas share common characteristics with mucosa-associated lymphoid tissue lymphomas","volume":"61","author":"Sato","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: The Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: Comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.pas.0000126775.27698.6e","article-title":"Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas","volume":"28","author":"Vergier","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2014.01.862","article-title":"Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis","volume":"70","author":"Tang","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCP4SUBR4NPSPTN","article-title":"Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions","volume":"143","author":"Doussau","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DAD.0b013e318255dbae","article-title":"Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient","volume":"35","author":"Fujiwara","year":"2013","journal-title":"Am. J. Dermatopathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1046\/j.0022-202x.2001.01543.x","article-title":"Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis","volume":"117","author":"Gellrich","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/DAD.0b013e31818118f7","article-title":"Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates","volume":"30","author":"Morales","year":"2008","journal-title":"Am. J. Dermatopathol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2020.09.014","article-title":"The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma","volume":"106","author":"Barasch","year":"2020","journal-title":"Hum. Pathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jid.2019.04.005","article-title":"Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire","volume":"139","author":"Koning","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/s41596-021-00506-4","article-title":"Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cells","volume":"16","author":"Caeser","year":"2021","journal-title":"Nat. Protoc."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/785\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:17:03Z","timestamp":1760120223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["cancers15030785"],"URL":"https:\/\/doi.org\/10.3390\/cancers15030785","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]}}}